Molecular Analysis Of Bladder Cancer

Sponsor
Lahey Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00871754
Collaborator
(none)
5,000
1
452
11.1

Study Details

Study Description

Brief Summary

This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    5000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Molecular Analysis Of Bladder Cancer
    Study Start Date :
    Apr 1, 1988
    Anticipated Primary Completion Date :
    Dec 1, 2025
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Bladder cancer

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Lahey Clinic Burlington Massachusetts United States 01805

      Sponsors and Collaborators

      • Lahey Clinic

      Investigators

      • Principal Investigator: Kim Reiger-Christ, PhD, Lahey Clinic

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Linda Topjian, study coordinator, Lahey Clinic
      ClinicalTrials.gov Identifier:
      NCT00871754
      Other Study ID Numbers:
      • 88-009A
      First Posted:
      Mar 30, 2009
      Last Update Posted:
      Jan 19, 2022
      Last Verified:
      Jan 1, 2022
      Keywords provided by Linda Topjian, study coordinator, Lahey Clinic
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Jan 19, 2022